BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1282 related articles for article (PubMed ID: 18538636)

  • 1. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study.
    Witt K; Daniels C; Reiff J; Krack P; Volkmann J; Pinsker MO; Krause M; Tronnier V; Kloss M; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G
    Lancet Neurol; 2008 Jul; 7(7):605-14. PubMed ID: 18538636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative impact of borderline global cognitive scores on quality of life after subthalamic nucleus stimulation in Parkinson's disease.
    Witt K; Daniels C; Krack P; Volkmann J; Pinsker MO; Kloss M; Tronnier V; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G
    J Neurol Sci; 2011 Nov; 310(1-2):261-6. PubMed ID: 21733529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of bilateral subthalamic nucleus deep brain stimulation (STN DBS) on cognition in Parkinson disease.
    Heo JH; Lee KM; Paek SH; Kim MJ; Lee JY; Kim JY; Cho SY; Lim YH; Kim MR; Jeong SY; Jeon BS
    J Neurol Sci; 2008 Oct; 273(1-2):19-24. PubMed ID: 18640690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial.
    Odekerken VJ; van Laar T; Staal MJ; Mosch A; Hoffmann CF; Nijssen PC; Beute GN; van Vugt JP; Lenders MW; Contarino MF; Mink MS; Bour LJ; van den Munckhof P; Schmand BA; de Haan RJ; Schuurman PR; de Bie RM
    Lancet Neurol; 2013 Jan; 12(1):37-44. PubMed ID: 23168021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of lead trajectory and electrode position to neuropsychological outcomes of subthalamic neurostimulation in Parkinson's disease: results from a randomized trial.
    Witt K; Granert O; Daniels C; Volkmann J; Falk D; van Eimeren T; Deuschl G
    Brain; 2013 Jul; 136(Pt 7):2109-19. PubMed ID: 23801735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic deep brain stimulation of the subthalamic nucleus for Parkinson's disease: effects on cognition, mood, anxiety and personality traits.
    Castelli L; Perozzo P; Zibetti M; Crivelli B; Morabito U; Lanotte M; Cossa F; Bergamasco B; Lopiano L
    Eur Neurol; 2006; 55(3):136-44. PubMed ID: 16682797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a meta-analysis.
    Parsons TD; Rogers SA; Braaten AJ; Woods SP; Tröster AI
    Lancet Neurol; 2006 Jul; 5(7):578-88. PubMed ID: 16781988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychological and psychiatric assessments following bilateral deep brain stimulation of the subthalamic nucleus in Japanese patients with Parkinson's disease.
    Aono M; Iga J; Ueno S; Agawa M; Tsuda T; Ohmori T
    J Clin Neurosci; 2014 Sep; 21(9):1595-8. PubMed ID: 24794694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporary deterioration of executive function after subthalamic deep brain stimulation in Parkinson's disease.
    Yamanaka T; Ishii F; Umemura A; Miyata M; Horiba M; Oka Y; Yamada K; Okita K; Matsukawa N; Ojika K
    Clin Neurol Neurosurg; 2012 May; 114(4):347-51. PubMed ID: 22176916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive effects of subthalamic nucleus stimulation in Parkinson's disease: a controlled study.
    Sáez-Zea C; Escamilla-Sevilla F; Katati MJ; Mínguez-Castellanos A
    Eur Neurol; 2012; 68(6):361-6. PubMed ID: 23095782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuropsychological changes and bilateral subthalamic deep brain stimulation in Parkinson's disease].
    Gómez JC; Lezcano E; Molano A; Lambarri I; Bilbao G; Garibi J; Madoz P; Zarranz JJ
    Neurologia; 2003 Apr; 18(3):139-45. PubMed ID: 12677479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is improvement in the quality of life after subthalamic nucleus stimulation in Parkinson's disease predictable?
    Daniels C; Krack P; Volkmann J; Raethjen J; Pinsker MO; Kloss M; Tronnier V; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G; Witt K
    Mov Disord; 2011 Dec; 26(14):2516-21. PubMed ID: 22170276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep brain stimulation and cognitive functions in Parkinson's disease: A three-year controlled study.
    Zangaglia R; Pacchetti C; Pasotti C; Mancini F; Servello D; Sinforiani E; Cristina S; Sassi M; Nappi G
    Mov Disord; 2009 Aug; 24(11):1621-8. PubMed ID: 19514093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between bilateral subthalamic nucleus deep brain stimulation (STN-DBS) and anxiety in Parkinson's disease patients: a controlled study.
    Chang C; Li N; Wu Y; Geng N; Ge S; Wang J; Wang X; Wang X
    J Neuropsychiatry Clin Neurosci; 2012; 24(3):316-25. PubMed ID: 23037645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuro-psychiatric therapy during chronic subthalamic stimulation in Parkinson's disease.
    Zibetti M; Pesare M; Cinquepalmi A; Rosso M; Castelli L; Rizzi L; Bergamasco B; Lanotte M; Lopiano L
    Parkinsonism Relat Disord; 2009 Feb; 15(2):128-33. PubMed ID: 18515169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep brain stimulation parameters associated with neuropsychological changes in subthalamic nucleus stimulation for refractory Parkinson's disease.
    Schoenberg MR; Mash KM; Bharucha KJ; Francel PC; Scott JG
    Stereotact Funct Neurosurg; 2008; 86(6):337-44. PubMed ID: 18854660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immediate effects of deep brain stimulation of the subthalamic nucleus on nonmotor symptoms in Parkinson's disease.
    Wolz M; Hauschild J; Koy J; Fauser M; Klingelhöfer L; Schackert G; Reichmann H; Storch A
    Parkinsonism Relat Disord; 2012 Sep; 18(8):994-7. PubMed ID: 22682974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep brain stimulation of the subthalamic nucleus and cognitive functions in Parkinson's disease.
    Klempírová O; Jech R; Urgosík D; Klempír J; Spacková N; Roth J; Růzicka E
    Prague Med Rep; 2007; 108(4):315-23. PubMed ID: 18780643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for executive dysfunction after subthalamic nucleus stimulation in Parkinson's disease.
    Daniels C; Krack P; Volkmann J; Pinsker MO; Krause M; Tronnier V; Kloss M; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G; Witt K
    Mov Disord; 2010 Aug; 25(11):1583-9. PubMed ID: 20589868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinson's disease patients with subthalamic stimulation and carers judge quality of life differently.
    Lewis CJ; Maier F; Eggers C; Pelzer EA; Maarouf M; Moro E; Zurowski M; Kuhn J; Woopen C; Timmermann L
    Parkinsonism Relat Disord; 2014 May; 20(5):514-9. PubMed ID: 24637125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.